De novo pemphigus vulgaris and pemphigus foliaceus development following COVID-19 infection and vaccination: Matched case-control study

J Eur Acad Dermatol Venereol. 2024 May;38(5):e374-e376. doi: 10.1111/jdv.19783. Epub 2024 Jan 12.

Authors

P G Arduino¹, A A Kubanov², A V Vlasova³, A A Martynov², S I Svishchenko², S Petti⁴

Affiliations

¹ Department of Surgical Science, University of Turin, Turin, Italy.
² State Research Center of Dermatovenereology and Cosmetology, Moscow, Russian Federation.
³ Sechenov First Moscow State Medical University, Moscow, Russian Federation.
⁴ Department of Public Health and Infectious Diseases, Sapienza University, Rome, Italy.

PMID: 38217309
DOI: 10.1111/jdv.19783

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
COVID-19 Vaccines / adverse effects
COVID-19* / complications
COVID-19* / prevention & control
Case-Control Studies
Female
Humans
Male
Middle Aged
Pemphigus*
SARS-CoV-2
Vaccination

Substances

COVID-19 Vaccines